| BPH Global Ltd (BP8) ORDINARY FULLY PAID |
Health Care |
$4 |
Coastal Bioremediation Talks with Indonesian Authorities
|
15 Jul 2025 9:30AM |
$0.002 |
$0.002 |
fallen by
25%
|
|
BP8 - Price-sensitive ASX Announcement
Full Release
Key Points
- BPH Global Ltd, through its subsidiary BP8 Sdn Bhd, is actively pursuing coastal bioremediation projects in Indonesia.
- The company has engaged in discussions with various Indonesian authorities regarding the deployment of its bioremediation technology.
- BP8’s bioremediation solution targets the treatment of coastal and marine pollution, particularly focusing on mitigating the effects of oil spills and other contaminants.
- Preliminary talks have been held with representatives from Indonesia’s Ministry of Environment and Forestry and other relevant governmental bodies.
- These interactions are part of BPH Global’s broader strategy to expand its environmental solutions footprint in Southeast Asia.
- The company views Indonesia as a significant market due to its extensive coastline and pressing need for sustainable environmental management.
- BP8’s technology was presented as a scalable, eco-friendly solution suitable for Indonesia’s coastal challenges.
- BPH Global is seeking to establish pilot projects as proof of concept in selected regions in Indonesia.
- The company is positioning its product as complementary to Indonesia’s ongoing environmental remediation and coastal management efforts.
- No definitive agreements have yet been reached, but discussions are ongoing and further updates will be provided as negotiations progress.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rey Resources Limited (REY) ORDINARY FULLY PAID |
Energy |
- |
Notice of change of interests of substantial holder
|
15 Jul 2025 9:29AM |
$0.028 |
$0.027 |
fallen by
3.57%
|
|
| Syntara Limited (SNT) ORDINARY FULLY PAID |
Health Care |
$41 |
First patient dosed in SATELLITE Phase 1c for keloid scars
|
15 Jul 2025 9:26AM |
$0.048 |
$0.021 |
fallen by
56.25%
|
|
| Pengana Private Equity Trust (PE1) ORDINARY UNITS FULLY PAID |
Financials |
$392 |
Update - Notification of buy-back - PE1
|
15 Jul 2025 9:26AM |
$1.170 |
$1.470 |
risen by
25.64%
|
|
| Imagion Biosystems Limited (IBX) ORDINARY FULLY PAID |
Health Care |
$6 |
Imagion MagSense Breast Cancer Program Phase 2 Trial Update
|
15 Jul 2025 9:26AM |
$0.014 |
$0.013 |
fallen by
7.14%
|
|
IBX - Price-sensitive ASX Announcement
Full Release
Key Points
- Imagion Biosystems Limited updated stakeholders on the Phase 2 MagSense breast cancer trial.
- The trial assesses MagSense nanoparticle imaging for detecting metastatic breast cancer lesions.
- Recruitment is progressing well with enrollment targets on track.
- Clinical milestones are being met as planned.
- The technology aims to improve diagnostic accuracy for breast cancer metastasis.
- Results could influence future regulatory submissions and commercialization.
- Collaboration with multiple clinical sites is ongoing.
- The update includes commentary on regulatory pathways and next steps for the program.
- The company remains focused on leveraging MagSense for broader diagnostic applications.
- Forward-looking statements address business strategy and potential market impact.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nova Minerals Limited (NVA) CHESS DEPOSITARY INTERESTS 12:1 |
Materials |
$122 |
Nova Announces Pricing of US$11.1m NASDAQ Offering
|
15 Jul 2025 9:26AM |
$0.300 |
$0.550 |
risen by
83.33%
|
|
NVA - Price-sensitive ASX Announcement
Full Release
Key Points
- Nova Minerals Limited has priced a US$11.1 million public offering on NASDAQ.
- The funds will be used to advance the Estelle Gold Project in Alaska, general corporate purposes, and working capital.
- Details of the offering include the number of shares and price per share.
- The announcement emphasizes the strategic importance of the Estelle Gold Project.
- Nova Minerals is listed on both NASDAQ and the ASX.
- The company outlines its exploration strategy and ongoing developments.
- The capital raise is expected to support the company’s growth and increase shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Iltani Resources Limited (ILT) ORDINARY FULLY PAID |
Materials |
$31 |
Final assay results received from Orient resource drilling
|
15 Jul 2025 9:23AM |
$0.200 |
$0.395 |
risen by
97.50%
|
|
ILT - Price-sensitive ASX Announcement
Full Release
Key Points
- Final assay results received from Orient resource drilling by Iltani Resources Limited
- Significant polymetallic mineralisation confirmed at Orient Project, including silver, zinc, lead, and indium
- Multiple drill holes intersected high-grade mineralisation zones
- Drilling focused on Orient West and Orient East prospects
- Results support the company's exploration model and strategy
- Further work planned, including geophysics, mapping, and additional drilling
- Progress towards defining a maiden mineral resource estimate
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Invion Limited (IVX) ORDINARY FULLY PAID |
Health Care |
$4 |
Invion Announces Results of Entitlement Offer
|
15 Jul 2025 9:22AM |
$0.105 |
$0.035 |
fallen by
66.67%
|
|
| Star Minerals Limited (SMS) ORDINARY FULLY PAID |
Materials |
$9 |
Native Vegetation Clearing Permit Application Submitted
|
15 Jul 2025 9:20AM |
$0.027 |
$0.035 |
risen by
29.63%
|
|
| 5G Networks Limited (5GN) ORDINARY FULLY PAID |
Information Technology |
$15 |
Change in substantial holding
|
15 Jul 2025 9:19AM |
$0.135 |
$0.058 |
fallen by
57.04%
|
|
| Regal Investment Fund (RF1) ORDINARY UNITS FULLY PAID |
Financials |
$725 |
Update - Notification of buy-back - RF1
|
15 Jul 2025 9:19AM |
$2.980 |
$3.480 |
risen by
16.78%
|
|
| Prescient Therapeutics Limited (PTX) ORDINARY FULLY PAID |
Health Care |
$65 |
Prescient Therapeutics Extends Share Purchase Plan
|
15 Jul 2025 9:18AM |
$0.043 |
$0.062 |
risen by
44.19%
|
|
PTX - Price-sensitive ASX Announcement
Full Release
Key Points
- Prescient Therapeutics Limited (PTX) extends its Share Purchase Plan (SPP)
- Extension granted to allow more eligible shareholders to participate
- The new SPP closing date is stated in the announcement
- Purpose of the SPP is to raise additional capital for development programs and working capital
- Shareholders are provided details on how to participate and the revised timeline
- PTX reiterates its commitment to clinical and corporate objectives
- Contact information for shareholder enquiries is included
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Argent Minerals Limited (ARD) ORDINARY FULLY PAID |
Materials |
$36 |
Commencement of Deeper Drilling at Kempfield Deposit
|
15 Jul 2025 9:18AM |
$0.025 |
$0.021 |
fallen by
16%
|
|
ARD - Price-sensitive ASX Announcement
Full Release
Key Points
- Argent Minerals Limited has started a deeper drilling program at the Kempfield Deposit.
- The Kempfield Deposit is located in New South Wales, Australia.
- The drilling aims to test deeper extensions of the known mineralization.
- Focus is on increasing the Kempfield resource base and discovering high-grade mineralized zones.
- Target metals include silver, lead, zinc, and gold.
- The program builds on prior successful drilling campaigns.
- Deeper drilling is expected to upgrade and expand the existing Mineral Resource Estimate.
- The initiative is a strategic step to unlock further value from the Kempfield project.
- Understanding the deposit's deeper geology is central to the program's objectives.
- Stakeholder value enhancement is emphasized as a key driver for the drilling campaign.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clime Capital Limited (CAM) ORDINARY FULLY PAID |
Financials |
$95 |
Update - Notification of buy-back - CAM
|
15 Jul 2025 9:16AM |
$0.705 |
$0.675 |
fallen by
4.26%
|
|
| Ironbark Balanced Income Limited (IBC) ORDINARY FULLY PAID |
Financials |
$43 |
Update - Notification of buy-back - IBC
|
15 Jul 2025 9:16AM |
$0.435 |
$0.425 |
fallen by
2.30%
|
|
| Graincorp Limited (GNC) ORDINARY FULLY PAID CLASS A |
Consumer Staple |
$1,080 |
Update - Notification of buy-back - GNC
|
15 Jul 2025 9:14AM |
$7.430 |
$4.860 |
fallen by
34.59%
|
|
| Rapid Critical Metals Limited (RCM) ORDINARY FULLY PAID |
Materials |
$37 |
Acquisition of High-Grade Silver Assets Presentation
|
15 Jul 2025 9:14AM |
$0.032 |
$0.031 |
fallen by
3.13%
|
|
| Verity Resources Limited (VRL) ORDINARY FULLY PAID |
Materials |
$6 |
Resource Upgrade and Expansion Drilling to Commence -Amended
|
15 Jul 2025 9:13AM |
$0.025 |
$0.013 |
fallen by
48%
|
|
VRL - Price-sensitive ASX Announcement
Full Release
Key Points
- VRL is launching a resource upgrade and expansion drilling campaign at its gold project.
- The program targets increasing resource confidence and expanding known mineralised zones.
- Drilling will involve both infill and step-out holes.
- Objectives include resource definition, potential expansion, and improving geological understanding.
- The company highlights strategic planning and responsible development practices.
- Stakeholder engagement and environmental considerations are acknowledged.
- The announcement provides technical details on drill targets and expected outcomes.
- The initiative positions VRL for future project development and exploration activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Janison Education Group Limited (JAN) ORDINARY FULLY PAID |
Information Technology |
$26 |
Contract for NZ Assessment & Aromatawai Tool
|
15 Jul 2025 9:12AM |
$0.150 |
$0.100 |
fallen by
33.33%
|
|
JAN - Price-sensitive ASX Announcement
Full Release
Key Points
- Janison has secured a contract with the New Zealand Ministry of Education.
- The contract is for the provision of a digital assessment and aromatawai tool for New Zealand schools.
- It is a multi-year agreement expected to provide recurring revenue.
- The technology will deliver national assessments digitally to students.
- This contract strengthens Janison’s presence in the Asia-Pacific education sector.
- The announcement confirms Janison’s leadership in scalable, robust online assessment solutions.
- The contract aligns with New Zealand’s education strategy for digital transformation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cardiex Limited (CDX) ORDINARY FULLY PAID |
Health Care |
$20 |
Notification regarding unquoted securities - CDX
|
15 Jul 2025 9:12AM |
$0.040 |
$0.036 |
fallen by
10%
|
|
| Baby Bunting Group Limited (BBN) ORDINARY FULLY PAID |
Consumer Discretionary |
$191 |
Advance notice of FY25 results release and 2025AGM
|
15 Jul 2025 9:10AM |
$1.830 |
$1.410 |
fallen by
22.95%
|
|
| EBR Systems Inc (EBR) CDI 10:1 US PERSON PROHIBITED EXCLUDING QIB |
Health Care |
$286 |
Preliminary Approval for TPT Reimbursement Received
|
15 Jul 2025 9:10AM |
$1.175 |
$0.380 |
fallen by
67.66%
|
|
EBR - Price-sensitive ASX Announcement
Full Release
Key Points
- EBR Systems Inc received preliminary CMS approval for TPT reimbursement of the WiSE CRT System.
- TPT payment will become effective July 1, 2024, for Medicare beneficiaries.
- The reimbursement aims to increase access to EBR’s leadless CRT technology in the US.
- Hospitals will be better able to provide the WiSE CRT System to eligible patients.
- Decision supports EBR’s US commercial strategy and patient access initiatives.
- The WiSE CRT System offers a leadless alternative for cardiac resynchronization therapy.
- EBR expects the reimbursement to drive broader adoption and clinical use of its system.
- The company emphasizes improved outcomes in heart failure patients as a core benefit.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WCM Global Growth Limited (WQG) ORDINARY FULLY PAID |
Financials |
$545 |
Weekly NTA 11 July 2025
|
15 Jul 2025 9:09AM |
$1.775 |
$1.970 |
risen by
10.99%
|
|
| Lumos Diagnostics Holdings Limited (LDX) ORDINARY FULLY PAID |
Health Care |
$99 |
Suspension from Quotation
|
15 Jul 2025 9:09AM |
$0.029 |
$0.105 |
risen by
262.07%
|
|
LDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Lumos Diagnostics Holdings Limited (LDX) suspended from quotation on the ASX effective 31 July 2023.
- Suspension is pending an announcement regarding LDX’s financial position.
- ASX Listing Rules and Guidance require the action to ensure continuous disclosure.
- The suspension is due to uncertainty about LDX’s ability to continue as a going concern.
- The company is expected to provide additional updates to the market as information becomes available.
- The announcement is part of maintaining market integrity and transparency.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aurum Resource Limited (AUE) ORDINARY FULLY PAID |
Materials |
$208 |
100 million share placement to strategic investors completed
|
15 Jul 2025 9:09AM |
$0.485 |
$0.510 |
risen by
5.15%
|
|
Call 1300 880 160
Start a chat
Schedule a call
